Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

René Rodriguez-Gutierrez

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Clinical Diabetes and Healthcare|March 30, 2023
Making Diabetes Care Fit-Are We Making Progress?Merel M Ruissen, René Rodriguez-Gutierrez, Victor M Montori, et al.
BMJ (Clinical Research Ed.)|November 7, 2019
Benefits and harms of intensive glycemic control in patients with type 2 diabetesRené Rodriguez-Gutierrez, José Gerardo Gonzalez-Gonzalez, Jorge A Zuñiga-Hernandez, et al.
Diabetes Research and Clinical Practice|March 5, 2022
Effect of metformin on microvascular outcomes in patients with type 2 diabetes: A systematic review and meta-analysisJosé Gerardo González-González, Ricardo Cesar Solis, Alejandro Díaz González-Colmenero, et al.
BMJ Open|July 2, 2018
Systematic review and meta-analysis of the effect of SGLT-2 inhibitors on microvascular outcomes in patients with type 2 diabetes: a review protocolEdgar Gerardo Dorsey-Treviño, Belinda Maricela Contreras-Garza, José Gerardo González-González, et al.
BMJ (Clinical Research Ed.)|August 14, 2025
Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guidelineArnav Agarwal, Reem Mustafa, Veena Manja, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guidelineSheyu Li, Per Olav Vandvik, Lyubov Lytvyn, et al.
BMJ (Clinical Research Ed.)|January 14, 2021
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trialsSuetonia C Palmer, Britta Tendal, Reem A Mustafa, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Clinical Diabetes and Healthcare|March 30, 2023
Making Diabetes Care Fit-Are We Making Progress?Merel M Ruissen, René Rodriguez-Gutierrez, Victor M Montori, et al.
BMJ (Clinical Research Ed.)|November 7, 2019
Benefits and harms of intensive glycemic control in patients with type 2 diabetesRené Rodriguez-Gutierrez, José Gerardo Gonzalez-Gonzalez, Jorge A Zuñiga-Hernandez, et al.
Diabetes Research and Clinical Practice|March 5, 2022
Effect of metformin on microvascular outcomes in patients with type 2 diabetes: A systematic review and meta-analysisJosé Gerardo González-González, Ricardo Cesar Solis, Alejandro Díaz González-Colmenero, et al.
BMJ Open|July 2, 2018
Systematic review and meta-analysis of the effect of SGLT-2 inhibitors on microvascular outcomes in patients with type 2 diabetes: a review protocolEdgar Gerardo Dorsey-Treviño, Belinda Maricela Contreras-Garza, José Gerardo González-González, et al.
BMJ (Clinical Research Ed.)|August 14, 2025
Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guidelineArnav Agarwal, Reem Mustafa, Veena Manja, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guidelineSheyu Li, Per Olav Vandvik, Lyubov Lytvyn, et al.
BMJ (Clinical Research Ed.)|January 14, 2021
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trialsSuetonia C Palmer, Britta Tendal, Reem A Mustafa, et al.
Pageof 1